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Abstract: Neurotransmitters are important chemical messengers in the nervous system that play a
crucial role in physiological and physical health. Abnormal levels of neurotransmitters have been
correlated with physical, psychotic, and neurodegenerative diseases such as Alzheimer’s, Parkinson’s,
dementia, addiction, depression, and schizophrenia. Although multiple neurotechnological
approaches have been reported in the literature, the detection and monitoring of neurotransmitters in
the brain remains a challenge and continues to garner significant attention. Neurotechnology that
provides high-throughput, as well as fast and specific quantification of target analytes in the brain,
without negatively impacting the implanted region is highly desired for the monitoring of the complex
intercommunication of neurotransmitters. Therefore, it is crucial to develop clinical assessment
techniques that are sensitive and reliable to monitor and modulate these chemical messengers and
screen diseases. This review focuses on summarizing the current electrochemical measurement
techniques that are capable of sensing neurotransmitters with high temporal resolution in real
time. Advanced neurotransmitter sensing platforms that integrate nanomaterials and biorecognition
elements are explored.
Keywords: neurotransmitters; electrochemical; biosensors; fast scan cyclic voltammetry; differential
pulse voltammetry; cyclic voltammetry
1. Introduction
A neurotransmitter (NT) is a chemical messenger that influences a wide variety of both
psychological and physiological functions. Their functions are directly linked to the central nervous
system that controls the human body and directly supervise neurophysiological processes such as
sleep, emotions, memory, and other cognitive functions [1,2]. Abnormalities in the concentration and
dysfunction of NTs in the central nervous system have been linked to a multitude of diseases such
as psychotic (schizophrenia, depression, dementia, etc.), neurodegenerative diseases (Alzheimer’s,
Parkinson’s, Huntington’s disease, autism, epilepsy, attention deficit hyperactivity disorder, etc.), and
other illnesses (glaucoma, arrhythmias, thyroid hormone shortage, congestive heart damage, sudden
infant death syndrome, dejection and anguish, etc.) [3,4]. German pharmacologist Otto Loewi was the
first to discover the most widely detected neurotransmitter, acetylcholine in 1921. The exact number of
unique NTs in humans is unknown, but more than 200 have been identified since 1921 [2].
NTs are classified according to their functions (excitatory and inhibitory), molecular structures
(amino acid group, biogenic amines, and soluble gases) and action (fast acting and slow acting). Most
NTs are difficult to classify according to the above categories. For example, dopamine (DA) can be
classified as excitatory and inhibitory, and acetylcholine and choline can be classified by other molecular
groups [5], hence NTs are generally classified according to their molecular structure, such as amino acid
based NTs (e.g., glutamic acid, tryptophan, Gamma-Aminobutyric Acid (GABA), L- aspartate, D-serine,
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glycine, histidine, and tyrosine), biogenic amines (e.g., acetylcholine, serotonin, histamine, epinephrine,
norepinephrine, and dopamine), and soluble gases (e.g., nitric oxide and hydrogen sulfide) [2,6].
Glutamate, histamine, and acetylcholine are examples of NTs that bear non-electroactive properties
and are difficult to measure without the presence of a biorecognition element such as an enzyme.
The enzyme is selective towards its target NT, wherein it converts the biorecognition event into an
analytical signal. The limitations of enzyme-based biosensors are their complex immobilization process
and instability due to the degradation of enzymatic activities overtime. However, electroactive NTs
can be easily detected using nonenzymatic sensors. Although these NTs biosensors are inexpensive,
biocompatible, and stable for most applications, their specificity or selectivity remain questionable.
Many biochemical species in the brain have similar oxidation–reduction potentials and the presence of
many interfering species hinders the deployment of nonenzymatic NTs biosensors as these types of
biosensors face difficulties in detecting specific target analytes in the brain.
Neurotransmitter analyses under in vitro and in vivo conditions are necessary for understanding
the functioning of the brain and its disorders because of their importance in clinical assessments [7–9].
However, NT concentrations in biological samples are relatively low (nM) and therefore require highly
sensitive, selective, and reliable biosensors to detect them. Several efforts have been employed to
develop transduction mechanisms for the detection of NTs, such as nuclear medicine tomographic
imaging (i.e., positron emission tomography and single-photon emission computed tomography),
optical sensing (i.e., surface-enhanced Raman spectroscopy, fluorescence, chemiluminescence, optical
fiber based biosensors, and colorimetry), analytical chemistry techniques (i.e., high performance liquid
chromatography), and microdialysis [10]. These reported techniques require highly trained personnel
and are time-consuming, thereby not suitable for point of care testing.
A rapid and accurate detection of NTs are key factors in point of care diagnostics for clinical and
medical applications. Electrochemical transduction methods have received significant attention and
are an ideal analytical approach for the characterization of biomolecules due to their low cost, ease
of use, small-size, and fast response time, as well as the possibility to detect two or more analytes
simultaneously [11,12]. In this review, we focus on electrochemical characterization techniques,
such as cyclic voltammetry (CV) including fast scan cyclic voltammetry (FSCV) and differential
pulse voltammetry (DPV) for the electrochemical sensing of glutamate (Glu), acetylcholine (AChE),
dopamine (DA), and serotonin (5-hydroxytryptamine (5-HT)). Electrochemical techniques have
significant advantages over conventional analytical techniques. They enable device miniaturization,
fast response time, high sensitivity, and good selectivity while being particularly suited for the detection
of neurotransmitters in the presence of mixtures of other biomolecules with high temporal resolution.
The various advancements made in the development of electrochemical transducers for single and
multiple analytes in vitro and in vivo are highlighted.
2. Biosensing of Neurotransmitters
Glutamate (L-glutamate acid) is a prominent amino acid neurotransmitter in the central nervous
system [2] in that almost 90% of all neurons use this amino acid as a primary messenger molecule.
The imbalance of glutamate concentrations through the neural pathways leads to neurological and
psychiatric disorders like Alzheimer’s diseases, Parkinson’s disease, autism, depression, stroke,
schizophrenia, and epilepsy. Therefore, being able to monitor changes in glutamate is valuable in
studying these disorders. Acetylcholine (AChE) is one of the most studied neurotransmitters and it
plays an important role in brain and muscle function. Imbalances in acetylcholine lead to neurological
conditions, such as regulating physiological levels of different neurotransmitters, opening of ligand-
gated ion channels, and the bursting mode of neuronal firing. Patients with Alzheimer’s disease,
Parkinson’s disease, and myasthenia gravis exhibit low levels of acetylcholine and the concentrations
of AChE vary in behavioral, learning, and sleep disorders [13].
Monamine neurotransmitters, dopamine and 5-hydroxytryptamine (5-HT) also know as serotonin
are of great clinical significance for the role they play in motor functions, emotional responses,
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motivations, and behavioral functions. An imbalance of dopamine has been associated with
physiological and psychological disorder. Increased dopaminergic activity may lead to errors in
perception such as hallucinations or psychiatric diseases such as schizophrenia. Additionally, deficiency
of dopaminergic neurons is often associated with neurological/motor diseases such as depression and
Parkinson’s diseases. Serotonin is known to regulate mood, sleep patterns, appetite, body temperature,
and hormonal activity. Some researchers hypothesize that low concentrations of serotonin contribute
to disorders such as anxiety and depression.
Since NTs play critical roles in the central nervous system and impact the severity of
neurodegenerative diseases, real-time detection of NTs is of great interest in neuroscience [14].
The human brain contains billions of neurons which communicate through trillions of synapses and
electrical channels. A concentration gradient of NTs is formed between neurons when exocytotically
released. The NTs act as ligands which reversibly bind to receptors on adjacent cells, causing a
conformational change which triggers a series of biochemical responses within the cell. Due to the
nanometer scale of the synapse and the micron scale of electrode probes, NT detection occurs in the
extracellular space as shown in Figure 1. The quantification of NT continues to be a challenge for most
conventional analytical methods due to the fast release and clearance of NT, low concentration levels,
and the presence of interfering analytes in the extracellular space.
Figure 1. (A) Neurotransmitters (green) are exocytotically released into the synaptic cleft and diffuse
into the extracellular matrix, bind to the receptors (blue), and trigger a series of downstream reactions
(red) in the axon of other neurons. (B) A model electrode drawn to scale in a network of neurons.
Adapted from [14].
Electrochemical transducers are traditionally modified using different electrocatalytic materials
and biorecognition elements (bioreceptors) to improve the sensitivity, selectivity, and reliability of the
transducer. Conductive polymers (CPs) have been used to modify and improve the catalytic activity
of the modified electrode surface via electrodeposition. The polymeric film modified transducer can
detect NTs in the presence of interference species [15,16]. Although polymeric modified biosensors
detect NTs, CPs are somewhat limited due to their low sensitivity and reliability because of the poor
electron transfer between the target molecule and the current collector [16]. Carbon based materials,
such as graphene, carbon nanotubes (CNTs), and carbon black activated carbon are widely used in the
fabrication of electrochemical transducers due to their good physical and chemical properties, high
conductivity, relative inertness, wide voltage range, and fast heterogeneous electron transfer [17,18].
For example, carbon microelectrodes have been used to directly detect and monitor the fast changes in
monoamine neurotransmitters, such as dopamine. Figure 2 shows that the electrochemical detection
of dopamine involves 2e−/2H+ oxidation–reduction (redox) reaction at an applied potential. The
oxidation product is dopamine quinone and the current generated from the transfer of 2 electrons and
the release of 2 protons is directly proportional to the concentration of dopamine. Thereby, enabling the
electrochemical quantification of dopamine. The three primary types of electrochemical transduction
A B 
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methods (cyclic voltammetry, fast scan cyclic voltammetry, and differential pulsed voltametry) for NT
detection are discussed in the subsequent sections.
Figure 2. Electrochemical oxidation of dopamine to dopamine quinone in a 2-electron oxidation when
a potential is applied to the transducer.
2.1. Neurosensing via Cyclic Voltammetry
Cyclic voltammetry (CV) is an indispensable tool in electrochemistry and is used to study the
electrocatalytic performance of electrodes, electrode sensing materials, and electron transfer involving
NTs. Generally, a fixed voltage is applied to a three-electrode system consisting of a working, counter,
and reference electrodes. Current flows between the working and counter electrode during a redox
chemical reaction and the reference electrode maintains a constant potential between the electrodes. The
positions, shapes of the redox peaks, and relative peak amplitudes generated in a cyclic voltammogram
are determined by the electron transfer rate and chemical stability of the analyte(s). The oxidation peak
generated is due to the oxidation of NT at the electrode surface and the amplitude of the oxidation
peak increases corresponding to higher concentration of the NT while the concentration can be directly
quantified using the peak current values. Considering these factors, CV has been explored as the
method to detect electroactive neurotransmitters.
An electrochemical biosensor array in which a nanoporous pseudo carbon paste (nano-PPCPE)
working electrode was developed for the simultaneous detection of glutamate and AChE [19]. The
nano-PPCPE is comprised of a mixture of graphite powder, polystyrene microspheres, and polymerized
pyrrole packed into glass tubes with a copper wire (Φ = 3 mm (inner)). The cyclic voltammogram
generated at a scan rate of 0.05 V/s indicated two anodic peaks belonging to glutamate and AChE.
Additionally, the sensor was capable of distinguishing between the two NTs, thereby implying a
selective and simultaneous detection of glutamate and AChE is feasible for multimodal detection of
NTs. A linear range of 0.5 µM—10 µM with the detection limit of 0.25 µM was demonstrated for
glutamate, while a linear range of 5 µM—200 µM with the detection limit of 0.15 µM was observed for
AChE. The electrochemical performance of the biosensor array demonstrated a high selectivity for the
simultaneous determination of glutamate and AChE.
Carbon nanotubes (CNTs) are considered hollow carbon structures composed of a rolling graphite
sheet, with nanometer scale walls and micrometer scale wall length. Carbon atoms are well arranged
in the carbon nanotubes walls via sp2 bonds, which form the stiffest tubes and strongest fibers [20].
According to the layer number of the graphite sheet, the CNTs can be divided into single- walled
carbon nanotube (SWCNT) and multi-walled carbon nanotubes (MWCNTs). SWCNT is structured of
only a single layer of a seamless molecular cylinder and MWCNT is comprised of more than two layers
of graphite sheets [20]. They both possess a unique combination of properties including electrical,
magnetic, optical, mechanical, and chemical properties, all of which offer great promise for a wide
range of applications. In addition, they provide a large active surface area and an electrocatalytic
activity that are advantageous in the development of electrochemical transducers [17,21,22]. Several
CNTs and graphene-based NT sensors have been reported [23–25] with enhanced catalytic activity,
wherein metallic nanoparticles (NPs) are anchored to both graphene and CNT substrate to provide
excellent electron mediation for electron transfer between nanoparticles and substrate. Furthermore,
NPs are widely used to modify the electrode surface due to their large specific surface areas, excellent
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of sensors [23,24,26,27]. Several electrochemical transducers incorporating NPs have been reported for
the fabrication of NT biosensors [7,28,29].
To enhance the sensitivity, selectivity, and stability of the CV technique for sensing NTs, CNTs have
been explored as sensing materials for electrochemical biosensors [17]. CNTs have been demonstrated
to promote electron transfer, electrocatalysis and electroanalysis processes because of their considerable
mechanical strength, high electrical conductivity, high surface area, good chemical stability, and relative
chemical inertness in most electrolyte solutions. A CNT paste electrode modified with sodium dodecyl
sulfate (SDS) has been reported for the selective detection of dopamine (DA) in the presence of ascorbic
acid (AA) and uric acid (UA) [30]. It was observed that a SDS-modified-CNT paste electrode resulted
in higher sensitivity and selectivity towards DA in the presence of AA and UA and exhibited better
performance than unmodified electrodes. A linear range of 1 µM–28 µM with a detection limit at
0.33 µM was observed for DA.
Furthermore, alternative electrode fabrication technology involving 3D printing has been used
with CNT yarns to develop a new platform for electrochemical sensing of dopamine in the presence of
UA and AA [31]. This innovative CNT yarn 3D printed electrode displayed promising electrocatalytic
activity for the redox reaction of DA in the presence of AA and UA. The peak potentials were found
to be at 50 mV, 305 mV, and 545 mV for AA, DA, and UA, respectively with a DA detection limit
of 0.87 ± 0.09 µM. The as-fabricated electrode showed high reproducibility and stability, and most
importantly introduced a new versatile platform, compatible with various sensor fabrication techniques
including screen-printing. The modification of the electrode surface with nanostructure materials is
paramount for the advancement of neurotechnology for the detection of NTs. However, despite the
decades of the implementation of CV techniques for the detection of NTs, the technique is limited to
in vitro applications and high NT concentrations. In addition, the scan rate is very low (hundreds of
millivolts/s) and the temporal resolution must be greatly improved for the detection of NTs in vivo.
The detection of NTs in vivo can be quite challenging due to the low concentrations and the transient
events occurring on the sub-second time scale. Therefore, a faster and more powerful technique
is required to detect NT events in real-time. Fast Scan CV (FSCV) is a powerful electrochemical
technique which has a fast scan rate of ≥400 V/s, thereby resulting in high temporal resolution. The
FSCV technique combines multiple scans taken over time to analyze the changes in neurotransmitter
kinetics [32]. The key difference between FSCV and CV is the extremely high scan rate used in FSCV
and the millisecond cycle duration (~100 ms). FSCV is suitable for neurotransmitter sensing in vitro
and in vivo and it is more convenient for in vivo applications because of its high temporal resolution
when compared to the conventional CV technique. FSCV can be multiplexed and combined with
microelectrode arrays to detect various NTs in addition to monitoring the electrophysiology signals in
real time, thereby, allowing the study of complex interactions in vivo and unraveling the relationship
between NTs to local field potentials.
Probe fouling is a challenge that needs to be overcome in the development of sensing technology.
It is the result of reaction byproducts that irreversibly adsorb onto the surface of the probe, thereby
negatively impacting the sensitivity of the sensing system. Various approaches have been taken to
minimize the biofouling of the electrode surface. Polyhistamine has been shown to foul the surface of
microelectrode probes, thereby hindering the detection of histamine [33,34]. Confounding studies on
the oxidation potential of histamine have led to in depth analysis on the electrochemical properties
of these molecules [35]. FSCV and X-ray photoelectron spectroscopy (XPS) were used to address the
conflicting literature proposing an oxidation potential of 1.5 V [33] versus 0.3 V [34] for histamine.
Pihel et al. observed that histamine oxidizes at 1.5 V by losing a single proton and single electron
and generating a free radical on a nitrogen in the imidizole ring, thereby leading to dimerization and
polymerization of histamine. The polyhistamine then electrostatically adheres to the electrode surface,
thus fouling the probe. The electropolymerization of the surface proteins was further confirmed with
XPS [33]. Nafion coating was explored to minimize the electrode fouling and the results agreed with
other works which found a 1.5 V oxidation potential as shown in Figure 3A [35]. Nafion was shown to
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decrease fouling by reducing histamine adhesion to the surface of the electrode, but as a result, the
initial anodic current was reduced. The peak recently seen by Hashemi et al. at 0.3 V was concluded
not to be a faradaic peak but change in current caused by surface adhesion of histamine as shown in
Figure 3B.
Figure 3. Fast scan cyclic voltammetry (FSCV) of 1 µM histamine at different switching potentials, a
holding potential of −0.4 V, and a scan rate of 400 V/s. (A) Peak current as the result of electrostatic
adhesion of histamine. (B) Faradaic peaks upon the reduction of histamine. Reprinted with
permission [35].
Serotonin is known also to foul electrode surfaces and as an additional challenge, it has the same
oxidation potential as dopamine due to the similarity between the two biomolecules. A single CNT
modified carbon fiber electrode was demonstrated in vivo to selectively detect serotonin and dopamine
in real time as shown in Figure 4 [36]. Simultaneously detection of serotonin and dopamine was
achieved by using the reduction potentials. Fouling was addressed by modifying the carbon fiber
probe with CNTs, which enhanced the redox peak current generated. The resistance of CNTs to fouling
has been observed in other studies, although interestingly the mechanism is not known [37,38].
Figure 4. False color plot visualization of the change in concentration of dopamine and serotonin on
single carbon nanotube. Reprinted with permission [36].
3,4-dihydroxyphenylacetic acid (DOPAC), a metabolite of dopamine, has identical oxidation and
reduction potentials to dopamine. The structures of DOPAC and dopamine are very similar, except that
DOPAC has a carboxyl group located where dopamine has an amine. The presence of this functional
group gives DOPAC a negative charge, whereas dopamine has a positive charge at physiological pH.
Previously, DOPAC was only measurable using microdialysis and liquid chromatography. However,
more recent work has demonstrated that physiologically relevant concentrations of DOPAC can
be detected at a polymer modified carbon fiber microelectrode [39]. Nafion coating was used as a
polymeric electrode coating to screen out the negative ions and provide a higher affinity for positively
charged compounds such as dopamine, whereas polyethyleneimine (PEI) was used to electrostatically
attract negatively charged compounds such as DOPAC. Nafion was shown to greatly reduce the signal
for DOPAC (Figure 5A) and PEI showed an increase in sensitivity of the signal when compared to the
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uncoated electrode (Figure 5B). A higher holding potential was used to allow for the preconcentration of
DOPAC by varying the holding potentials to include positive, negative, and neutral holding potentials.
The optimal holding potential for the detection of DOPAC was determined to be 0 V as opposed to
−0.4 V for dopamine with a limit of detection of 52.25 ± 2 nM DOPAC, which was found to be within
the physiological range reported by Hashitani et al. [40].
Figure 5. Fast scan cyclic voltammetry scans for 3,4-dihydroxyphenylacetic acid (DOPAC) with nafion
(A) and polyethyleneimine (PEI) (B). Reprinted with permission [39].
Non-electroactive NTs require the use of enzymes for their detection. One such NT is glutamate.
Hunsberger et al. demonstrated in vivo glutamate sensing in mice with high spatial resolution [41].
Simultaneous measurements in subregions of the brain were achieved using microelectrode arrays
implanted in the dentate gyrus, cornu ammonis 3, and cornu ammonis 1 hippocampal subregions.
Glutaraldehyde was used as the crosslinking agent for the immobilization of glutamate oxide onto
the microelectrodes [42]. A size exclusion layer of electroplated m-phenylenediamine successfully
prevented interference from ascorbic acid and dopamine. High spatial resolution as well as temporal
resolution was achieved in vivo for glutamate with a linearity of 0 to 20 µM (R2 = 0.90) and a limit of
detection of 1.5 µM. The in vivo detection of glutamate enabled the study of the pharmacological effects
on glutamate release and reuptake, as well as the impact on the various regions of the brains. Although
the microelectrodes employed in this study achieved high temporal resolution, most electrodes are
limited to a temporal resolution of 10 Hz. This can be attributed to an incomplete reverse reaction,
causing local concentrations of NT to be converted to the oxidized state.
Zestos et al. investigated the physical characteristics and sensing capabilities of fabricated CNT
microelectrodes and carbon fiber microelectrodes (CFMEs) and observed a 50× increase in the temporal
resolution and 8× increase in the sensitivity of the CNT microelectrodes [43]. These microelectrodes
exhibit a high density of carbon edge-planes serving as the catalytic sites for neurotransmitter oxidation.
Additionally, the “rough” surface of the electrodes (Figure 6) provided higher catalytic surface area
and steric trapping of the NT. The rough surface morphology provided a large surface area for the
oxidation of dopamine. The sensing capabilities of a carbon yarn, PEI- CNT fibers, and CFMEs were
characterized across a range of scan rates, frequencies, and dopamine concentrations [44,45]. A limit
of detection of 24 ± 2 nM, 10 ± 0.8 nM, 3 ± 0.5 µM, and 5 ± 1 µM dopamine were obtained for the
unmodified CFME, prefabricated CNT yarn, acid-spun CNT fibers, and PEI-CNT fibers, respectively.
Figure 6. Cross-sectional SEM images of carbon nanotube (CNT) yarn (A), PEI-CNT fiber (B), and acid
spin CNT fiber (C). Reprinted with permission [43].
A. DOPAC_nafion B. DOPAC PEI 
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The electrochemical characterization showed that the responses of the fibers were frequency
independent up to 500 Hz as shown in Figure 7. Thereby enabling higher temporal resolution as
compared to the standard cycle frequencies of CFME (10 Hz) with a scan rate of 400 V/s. The steric
trapping of the dopamine quinone on the surface of the fibers was observed to allow for a far more
reversible reaction as compared to CFMEs. The high reversibility of the reaction allowed for faster
scan rates with higher temporal resolution and potentially may serve as a better electrode platform for
studying firing patterns at synaptic junctions in vivo.
Figure 7. CV of 1 µM dopamine at 2000 V/s for (A) carbon fiber microelectrode (CFME) (B) CNT yarn,
and (C) PEI-CNT fiber electrodes, demonstrating a consistent signal even at a high temporal resolution
of PEI-CNT fibers. Reprinted with permission [43].
A persistent limitation of carbon-based microelectrodes for FSCV lies in the fabrication and
production of these microelectrodes. The fabrication process requires manual assembly of carbon
fiber using the glass pulling technique, which is time consuming, inefficient, and requires a trained
technician. This limitation can be improved by using micro-/nanolithography fabrication techniques to
produce hundreds of sensors on a single wafer. Recently, a dopamine sensor was developed with over
6000 glassy carbon nanorod probes in a single array [46] using lithography and pyrolysis to enable
highly scalable microelectrode fabrication. The fabricated glassy carbon nanorods were similarly as
sensitive as a carbon fiber (7 nA/µM vs. 5 nA/µM), with comparable limits of detection (LOD = 60 nM
vs. 41 nM), respectively. A linear range of 1–10 µM (R2 = 0.9867) dopamine with a sensitivity of 7 ± 3
nA/µM was observed. The fabricated multiprobe array has the potential to provide higher sensitivity,
spatial resolution, and ease of fabrication, thereby allowing high throughput detection and monitoring.
Though significant advancement has been made to minimize the limitations associated with sensitivity,
selectivity, and temporal resolution through the use of FSCV, there still remain an increased demand
for new analytical techniques to successfully remove these barriers to NT detection and monitoring to
enable the understanding of neurophysiology in clinical research.
2.2. Neurosensing via Differential Pulse Voltammetry
Differential pulse voltammetry is a derivative of linear sweep voltammetry or staircase
voltammetry, wherein a series of regular voltage pulses are superimposed on the potential linear
sweep or stairsteps. This technique is very sensitive and allows for the simultaneous direct analysis
of multiple NTs using a single probe with good sensitivity. Wu et al. employed DPV technique for
the determination of dopamine (DA) and serotonin (5-HT) using carbon nanotube film-coated glassy
carbon electrode (GCE) [47]. It was observed that DA and 5-HT yield two well-defined oxidation peaks
at 0.18 V and 0.36 V, respectively. The oxidation peak current increased significantly with the MWCNT
coating in contrast to bare GCE. A large excess of interfering analyte, AA resulted in an insignificant
influence on the oxidation signals of DA and 5-HT. With a scan rate of 20 mV/s, a linear range of 0.05
µM–5 µM DA and detection limit of 0.011 µM were observed. For 5-HT, the linear range reported was
from 0.02 µM to 5 µM with a detection limit of 5 nM. MWCNT-modified electrodes are promising for
in vivo and in vitro measurements of DA and 5-HT.
Gold (Au) nanoclusters on insulating overoxidized-polypyrrole (PPyox) GCE (nano-
Au/PPyox/GCE) have been shown to improve the detection of dopamine and serotonin [48]. Detection
A. CFME B. CNTYarn C. PEI-CNT fiber 
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of these analytes in a mixture was possible even at overlapping anodic peaks for 5-HT, DA and AA.
The voltammetric peaks were observed at 0.37, 0.20, and 0.01 V by overlapping anodic peaks of 5-HT,
DA, and AA (1000-fold), respectively. The linear responses were in the range of 7 nM–2.2 µM with a
detection limit of 1.0 nM for 5-HT, and in the range of 0.75 µM–20 µM with a detection limit of 0.15
nM DA. This highlights the electrocatalytic activity of nano-Au/PPyox/GCE towards DA and 5-HT
oxidation, wherein an improvement was observed in the overall current response and the oxidation
overpotentials were lowered as the result of the synergic effect of the PPyox and Au nanoclusters. A
comparative plot of DPVs for the detection of DA and 5-HT in human serum using modified glassy
carbon electrodes is shown in Figure 8.
Figure 8. Differential pulse voltammetry (DPV) of dopamine (DA) and serotonin (5-HT) in the human
serum conducted using (A) MWCNT—DHP film-coated GCE for (a) 0, (b) 0.05, (c) 0.1, (d) 0.2, (e) 0.4 µM
DA and 5-HT. (B) DPVs of DA + 5-HT at nano-Au/PPyox/GCE with variously spiked concentrations:
(a–i) 0, 0.05, 0.1, 0.25, 0.5, 0.8, 1.3, 1.8, 2.2 µM. Reprinted with permission [47,48].
A lower detection limit for DA was achieved by developing highly sensitive acid functionalized
MWCNT modified GCEs for simultaneous electrochemical determination of DA and acetaminophen
(AP) in biological fluids [49]. Oxidation peaks at 125 mV and 307 mV were observed for DA and AP,
respectively with good stability, reproducibility, repeatability, and high recovery in human serum. The
linear dynamic ranges of 3–200 µM DA (R2 = 0.992) with a detection limit of 0.8 µM DA and 3– 300 µM
AP (R2 = 0.989) with a detection limit of 0.6 µM AP were observed. A pre-concentration step was used
to allow the accumulation of these species at the electrode surface and subsequently resulted in well
separated voltammetric peaks for sensitive and selective determination of DA and AP as shown in
Figure 9.
A biosensor array of vertically aligned carbon nanofibers (CNF) [50] was developed using plasma
enhanced chemical vapor deposition (PECVD). The CNF electrode was reported to be effective in
detection of DA and 5-HT in the presence of AA. The oxidation current was larger for CNF than GCE
for individual mixtures of DA/AA and 5-HT/AA. In the ternary mixture of AA, DA, 5-HT, the GCE
was unable to distinguish all three species due to overlapping peaks. Thereby, unmodified GCEs are
unsuitable for simultaneous detection of NTs. In contrast the CNF electrode can distinguish DA and
5-HT when they co-exist in the same solution. The CNF electrode demonstrated superior sensitivity
towards DA, with detection down to 50 nM in comparison to 100 nM for GCE. The CNF electrode
shows two linear ranges, from 100 nM–500 nM DA (R2 = 0.9996) and from 1 µM–10 µM 5-HT (R2 =
0.9603). Both CNF and GCE electrodes detect down to 100 nM for DA. A linear range from 1 µM–10 µM
5-HT (R2 = 0.9970) was observed. This suggests CNF electrodes are a great alternative to CNT-modified
GCE and graphene-modified GCE.
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Figure 9. DPV voltammograms of increasing concentrations of DA and AP at a f-MWCNT modified
electrode. Reprinted with permission [49].
A silver nanoparticles (AgNPs) over penicillamine self-assembled gold electrode [51] was
developed for the detection of DA and epinephrine (EP) in the presence of high concentration
of AA and uric acid at neutral pH. AgNPs were employed due to their catalytic properties and high
electrical conductivity. An enhancement in the electrode sensitivity, selectivity, as well as a wide linear
dynamic range with nanomolar detection limit were observed. Chronoamperometry was carried out
for the determination of DA and EP in the linear range of 0.1–100.0 mM with detection limits of 0.2 nM
DA and 0.5 nM EP. Simultaneous detection of DA and EP was performed using DPV. Figure 10 shows
the voltammograms for DA and EP with different concentrations. In the presence of 0.2 mM EP, the
peak current of DA was linear from 0.2–1.0 mM.
Figure 10. (A) DPV voltammograms of increasing concentrations of DA and EP in 0.1 M PBS at
AgNPs-PCA-Au electrode. (B) Plot of current as a function of concentration of DA and EP. Reprinted
with permission [51].
Graphene is an allotrope of the carbon family with a two-dimensional layer of carbon atoms
arranged in a honeycomb-structured network. Graphene has attracted a great deal of attention
due to its outstanding and novel properties such as high active surface area, high electrical
conductivity, strong mechanical strength, and good chemical stability [52–54]. Some graphene-based
neurotransmitters have been published [54,55]. Additionally, a microfluidic device has attracted
attention in the development of NT biosensing platforms for the purpose of microliter sample
detection [55]. A poly(diallyldimethylammonium) chloride-reduced graphene oxide (PDDA-RGO)
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dopamine and 5-HT with high sensitivity (0.016 µM and 0.0098 µM), wide linear range (0.05–120.0
µM), good stability (30 day storage), and repeatability for 20 µL sample volume detection [55].
The amalgamation of MWCNT and reduced graphene oxide (RGO) showed promising electrical
conductivity, electrochemical stability, and electrochemical performance. The linear ranges obtained
were 0.05–120.0 µM DA with limit of detection of 0.016 µM DA (S/N = 3) and 0.05–50.0 µM 5-HT with
limit of detection of 0.0098 µM 5-HT (S/N = 3). Good sensitivity and selectivity were observed for
dopamine and 5-HT in microliter volume rat’s plasma showing that DPV combined with carbon-based
materials has the potential to detect multiple NTs in biological samples at the sample time, although the
technique is limited by lower temporal resolution when compared to FSCV. Moreover, concentration
changes on the order of minutes can be easily detected using DPV but capturing events that occur on
the order of sub-second intervals in real-time requires the use of FSCV.
3. In Vivo Sensing
Techniques have evolved from developmental to translational research with the establishment of
standardized methods for in vivo experiments [56,57]. It is important to mention that the suitability
of in vivo over in vitro NT sensing relies on the specific application. For example, in vitro is suitable
for clinical applications, whereas in vivo is more applicable for continuous monitoring to detect the
state of diseases in a timely manner. However, in vivo often give rise to more complex electrodes with
lower sensitivity and higher cost. In addition, the techniques with higher sensitivity and reliability
are often large, bulky, and require time-consuming manipulations. The NTs released or secreted into
the extracellular space by exocytosis can be determine via in vitro and in vivo experiments. Carbon
fiber microelectrodes and ceramic electrodes are the most commonly used electrodes that can be easily
functionalized with enzymes specific for the target NT [57]. For in vivo analysis, the electrodes are
implanted or semi-implanted in the specific regions of the brain [32]. It has also been reported that
ceramic based electrodes functionalized with glutamate oxidase can detect glutamate in in vivo rodent
and swine models [40,58]. The sub-second temporal resolution of the microelectrodes have allowed
monitoring of the release and uptake of glutamate in the hippocampal region of the brain which occurs
in milliseconds. The use of validation studies has allowed for in vitro studies to be translated to in vivo
studies, where NTs have been detected in awake behaving animals including DA, 5-HT, Glu, and
AChE [58,59].
DA and 5-HT have been simultaneously detected in vivo using DPV [60]. A custom CFME was
functionalized with graphene and a metallophthalocyanine to enhance the electrocatalytic capabilities
of the electrodes. Figure 11A shows the voltammogram of 5-HT at the fabricated and bare electrodes.
An enhanced oxidation peak was observed with the graphene modified CFME. Concentrations of 5-HT
and DA were measured simultaneously using DPV at about 10-m intervals one hour after the final dose
for the duration of 1 h in mice. Although DPV is a sensitive technique that can simultaneously detect
multiple analytes with a single probe, it is limited by its low temporal resolution, as demonstrated by
the 10-m intervals shown in Figure 11B, compared to the sub-second intervals of FSCV.
The current challenges associated with microelectrode probes for the detection of NT include
enhancing their longevity, durability, and minimizing tissue damage during implantation. Longitudinal
studies have been performed to examine the extent of glial scarring with various probe electrodes [61,62].
The stability and sensitivity of chronically implanted electrodes have been characterized for up to
four months [63] and have been utilized in electrochemical characterization in vivo using rodent [41],
pig [41,64], primate [62], and even human models [65]. Tissue damage during implantation can lead to
glial encapsulation of the probe. Parylene [66], silicone [61], and carbon electrodes [63] have been used
in chronic implantation, wherein the electrode headstage is fixed to the live animal by performing
stereotaxic surgery to target a region in the striatum. When tissue is damaged, glial cells surrounding
neurons form a protective barrier, resulting in “glial scarring”. Immunostaining techniques and
transgenic reporter animals have been used to visualize the extent of glial scarring, as shown in
Figure 12.
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Figure 11. (A) CV voltammogram of 5 µM serotonin at the bare microelectrode (black), and the GR-
FeTSPc functionalized probe (red). (B) Concentration of DA obtained in vivo every 10 m with the
following experimental conditions: (a) administration group given Uncaria rhyunchophylla, (c) the
control administration group given antipsychotics, (d) the negative control group given saline and 5-
HT at (b) the negative control group, (e) control administration group, and (f) administration group.
Reprinted with permission [60].
Figure 12. Astrocytes expressing GFP local to probe implantation (probe) and the adjacent area (distant)
in vivo mice model. An increased density of astrocytes is associated with glial scarring. Reprinted with
permission [61].
Parylene based electrodes of various geometries implanted in rats for over four weeks showed that
electrodes less than 12 µm in thickness did not cause glial encapsulation based on qualitative
immunostaining [66]. A study using silicone probes investigated the long-term stability of
electrophysiology recording and glial scaring in live mice [61]. A consistent reading was obtained for
up to 10 weeks post implantation. Transgenic reporter mice are known to express green fluorescent
protein (GFP) in astrocytic glial cells (BAC Aldh1l1-GFP+/−) and this was used to visualize the extent
of glial scarring. After an initial spike, there was no significant increase in scarring from the second
week to the tenth week post implantation. The probe dimensions were 10 mm in length, 100 µm in
width, and 50 µm thick. Electrodes with less than 12 µm thickness, it was suggested, can minimize
scarring [67]. Regardless of the initial glial scarring observed during the first week (Figure 12), no
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Carbon fiber electrodes have been shown to provide stable and consistent readings in vivo over a
4-month study on mice [63]. Electrically stimulated and food stimulated DA responses were detected
at one, two, and four months after implantation. Immunostaining results showed no loss of signal
in either the in vivo stimulated DA response, or in the in vitro sensitivity analysis. No gliosis was
detectable after a 4-month period, which was attributed to the geometry of the electrode (diameter
< 12 µm). However, a higher degree of temporal distortion was observed when compared to acute
experiments performed by the same group [63]. Mathematical deconvolution methods have been
proposed to address temporal distortion for more precise analysis of long-term studies, such as that
developed for primates [62].
Chronically implanted probes in primates were found to lack structural integrity, where mechanical
failure from user handling and sudden primate head movement caused irreparable fractures in the
silica insulation of the probe [62]. Three probes failed immediately upon implantation and the rest of
the probes failed within 176 days after implantation. However, the behavioral and induced responses
to stimulus in various regions of the primate brain for over 100 days were studied [66]. As shown in
Figure 13, an array of four working electrodes were implanted in the striatum parallel to acute, reference,
and counter electrodes. A stimulation electrode was implanted in the ventral tegmental/substantia
nigra to generate electrically stimulated responses. FSCV at a frequency of 10 Hz showed successful
neurochemical responses that correlated to behavior and learning.
Figure 13. (A) A schematic of the implanted electrode. (B) Photograph of the implanted working
electrode. (C) MRI of the striatal target site highlighted in purple. Reprinted with permission [62].
Deep brain stimulation (DBS) is an established technique used to invoke a dopaminergic response
and has been used for the treatment of neurodegenerative diseases, such as Parkinson’s and epilepsy [65].
Although the therapy has been widely successful [67], the underlying mechanisms of DBS are not
well understood. Electrophysiology sensing is relatively common during these procedures, where the
electrical recordings are collected with the DBS lead continually. Acute neurotransmitter detection in
humans has been performed during DBS surgery at the Mayo Clinic by FSCV [65]. FSCV is performed
for the duration of the surgical procedure, then the electrode is removed while the DBS replaces
the electrophysiology electrode for continuous therapeutic stimulation. FSCV is interpreted using
the Wireless Instantaneous Neurochemical Concentration Sensing (WINCS) system. This system
generates the waveform, digitizes the electrochemical signal, and transmits the resulting signal to
a base station using Bluetooth to enable the investigation of the role of DA in decision making [68].
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4. Conclusions
In this review, we summarized the recent development of electrochemical sensors for the detection
of NTs. Given the ultralow concentration of NTs (~nM) and the abundance of biomolecules present in
the extracellular space, the exact quantification of NTs in vivo remains a challenge as NTs are locally
generated in a specific region of the brain. With the advancement in nanobiosensing, various carbon,
metallic, and polymeric nanocomposite sensing materials have been integrated on microelectrodes
for rapid detection of NTs due to their outstanding properties, such as high catalytic activities,
electron transfer rates, and high electrical conductivity. These sensing materials have been widely
reported to exhibit fast response time, as well as improved sensitivity and selectivity due to their
synergistic electrocatalytic activity towards target NTs and the fact that they can be fabricated at lower
cost. Polymer materials are widely used for reducing the effects of biofouling and interference from
competing and noncompeting analytes and have been shown to be biocompatible. CV, FSCV, and DPV
are electrochemical techniques used for the detection of NTs. CV is limited to in vitro applications and
required high concentrations of NT and DPV to enable the simultaneous detection of multiple NTs on
a single probe, whereas FSCV enables the rapid detection on NTs with high temporal resolution. The
temporal resolution on CV is however low compared to FSCV. Therefore, amongst the electrochemical
detection techniques discussed, FSCV is the most convenient technique for rapid detection of NT
in vitro and in vivo as it provides higher temporal and spatial resolution. Non-electroactive NTs are
detected with a biorecognition element such as an immobilized enzyme on the electrode surface.
However, the complex immobilization procedure, enzyme denaturation overtime, and the lack of
simultaneous multianalyte detection pose significant challenges for enzyme-based biosensors.
Future advancements are focused on the development of high throughput miniaturized probe
arrays using micro-/nanofabrication techniques and the integration of nanostructured sensing materials
to improve the long-term stability, sensitivity, selectivity, and reproducibility for rapid diagnostic
and point-of-care detection of NTs in real-time. Paired with electrophysiology and DBS, modern
techniques can be developed to provide new modalities for neuroscience, medical treatment, and
translational research. Extensive validation studies have culminated in providing meaningful insights
from in vivo studies that show inconsequential effects of tissue damage and allow for the development
of ground-truth based signal sorting algorithms. Wireless communication of electrochemical signals
generated from FSCV allows a high degree of freedom, which is important for removing restrictions
on head movement as an extraneous variable for studying psychological effects and will lead to the
reduction physical damage to the electrode or subjects during in vivo studies.
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